Incidence of prostate cancer after termination of screening in a population-based randomised screening trial

European Urology

Volumn 64, Issue 5, 2013, Pages 703-709

  Grenabo Bergdahl, Anna ^a   Holmberg, Erik ^a   Moss, Sue ^b   Hugosson, Jonas ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Age; Incidence; Prostate cancer; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GLEASON SCORE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

AGE; INCIDENCE; PROSTATE CANCER; SCREENING;

AGE FACTORS; AGED; DISEASE-FREE SURVIVAL; HUMANS; INCIDENCE; KALLIKREINS; KAPLAN-MEIER ESTIMATE; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGISTRIES; RISK FACTORS; SWEDEN; TIME FACTORS;

EID: 84885419324     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.05.024     Document Type: Review

References (21)

1. J.A. Salomon, H. Wang, and M.K. Freeman Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010 Lancet 380 2012 2144 2162
2. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
3. J. Hugosson, S. Carlsson, and G. Aus Mortality results from the Goteborg randomised population-based prostate-cancer screening trial Lancet Oncol 11 2010 725 732
4. F.H. Schroder, J. Hugosson, and M.J. Roobol Prostate-cancer mortality at 11 years of follow-up N Engl J Med 366 2012 981 990
5. G. Aus, S. Bergdahl, P. Lodding, H. Lilja, and J. Hugosson Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer - results from a prospective, population-based randomized controlled trial Eur Urol 51 2007 659 664
6. J.A. Hanley Measuring mortality reductions in cancer screening trials Epidemiol Rev 33 2011 36 45
7. D.H. Howard Life expectancy and the value of early detection J Health Econ 24 2005 891 906
8. L.C. Walter, and K.E. Covinsky Cancer screening in elderly patients: a framework for individualized decision making JAMA 285 2001 2750 2756
9. K.N. Stamatiou Elderly and prostate cancer screening Urol J 8 2011 83 87
10. G. Aus, C.C. Abbou, and M. Bolla EAU guidelines on prostate cancer European Urol 48 2005 546 551
11. R.A. Godtman, E. Holmberg, A. Khatami, J. Stranne, and J. Hugosson Outcome following active surveillance of men with screen-detected prostate cancer: results from the Göteborg randomised population-based prostate cancer screening trial Eur Urol 63 2013 101 107
12. S.K. Bechis, P.R. Carroll, and M.R. Cooperberg Impact of age at diagnosis on prostate cancer treatment and survival J Clin Oncol 29 2011 235 241
13. M. Tornblom, H. Eriksson, and S. Franzen Lead time associated with screening for prostate cancer Int J Cancer 108 2004 122 129
14. V. Nelen, G. Thys, and A. Hermans Interval cancers in the Antwerp European randomised study of screening for prostate cancer study, using a 6 year screening interval Eur J Cancer 46 2010 3090 3094
15. M. Popiolek, J.R. Rider, and O. Andrén Natural history of early, localized prostate cancer: a final report from three decades of follow-up Eur Urol 63 2013 428 435
16. P.C. Albertsen, D.F. Moore, W. Shih, Y. Lin, H. Li, and G.L. Lu-Yao Impact of comorbidity on survival among men with localized prostate cancer J Clin Oncol 29 2011 1335 1341
17. A. Bill-Axelson, L. Holmberg, and M. Ruutu Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 2011 1708 1717
18. A. Vickers, C. Bennette, and G. Steineck Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial Eur Urol 62 2012 204 209
19. H.G. Welch, P.C. Albertsen, R.F. Nease, T.A. Bubolz, and J.H. Wasson Estimating treatment benefits for the elderly: the effect of competing risks Ann Intern Med 124 1996 577 584
20. R. Gulati, J.L. Gore, and R. Etzioni Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms Ann Intern Med 158 2013 145 153
21. Life expectancy by sex and age. Year 2013-2110. Statistics Sweden. www.scb.se.